Piramal Enterprises Limited

Piramal Life Sciences Limited

Council of Scientific & Industrial Research

Nicholas Piramal India Limited

Swati Ajay Piramal

Veena R Agarwal

Gandhali Ashwin Deshpande

Muralidhara Padigaru

Satyawan Singh

Anil Kumar Dwivedi

Ram Pratap

Sunil Kumar Puri

Sudhir Srivastava

Ram Chandra Gupta

Omkar Prasad Asthana

Triptikumar Mukhopadhyay

Harsh Pati Thapliyal

Guru Prasad Dutta

Pratima Srivastava

Vikash Chandra Pandey

Shio Kumar Singh

Jagdishwar Sahai Srivastava

Amiya Prasad Bhaduri

Shripad Rhushikesh Jathar

Vidya Narayan Acharya

Rajesh Prabhamal Sirwani

Prakash Malhotra

Francis Joseph Pinto

The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.

Compounds for the treatment of cancers associated with human papillomavirus

The present invention relates to bioadhesive compositions for oral application, which comprise a curcuminoid substance as an active ingredient. The present invention also relates to method of using said bioadhesive composition for the prevention and treatment of periodontal diseases such as gingivitis and other periodontal diseases.

Herbal compositions for the treatment of diseases of the oral cavity

The present invention relates to the use of standardized extract ofas an immunoadjuvant in the treatment of renal disorders such as nephrotic syndrome and chronic recurrent urinary tract infections, both complicated and uncomplicated. The present invention also relates to pharmaceutical compositions comprising the standardized extract of The present invention further relates to a method of treatment of renal disorders such as recurrent urinary tract infection particularly occurring due to relapsingand other gram negative infections and to a method of treatment of nephrotic syndrome using standardized extract ofas an immunoadjuvant in conjunction with conventional therapy.

Herbal extract for renal disorders

A combination kit for the treatment of malaria caused by() having individual doses of an anti-malarial agent, 3-[1-[[4-[(6-methoxy-8-quinolinyl)amino]pentyl]amino]ethylidene]-dihydro-2(3H)-furanone (I) in the form of capsules; individual doses of the anti-malarial agent, chloroquine in the form of tablets; and instruction material for the administration of the two anti-malarial drugs. The combination kit is particularly suited for a 6 days treatment regimen where the treatment is rendered by five tablets containing 500 mg of chloroquine phosphate (equivalent to 300 mg base), three to be taken on day one and one each on days two and three; and five capsules containing 25 mg of 3-[1-[[4-[(6-methoxy-8-quinolinyl)amino]pentyl]amino]ethylidene]-dihydro-2(3H)-furanone (I), one each to be taken on days two to six.

Combination kit used in the treatment of malaria

Growing community of inventors

Mumbai, India

Swati Ajay Piramal